Jinhong Gong

机构：Nanjing Traditional Chinese Medicine Hospital, Second Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People's Hospital, Changzhou Third People's Hospital · ORCID：0000-0002-3963-3177

发表论文 37 篇 · 总被引 443 次 · h-index 12

代表论文

• Hesperetin, a Promising Treatment Option for Diabetes and Related Complications: A Literature Review (2022 · Journal of Agricultural and Food Chemistry · 被引 48)
• A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy (2022 · Acta Biomaterialia · 被引 39)
• Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway (2023 · iScience · 被引 27)
• Cost-Effectiveness of Tislelizumab Versus Docetaxel for Previously Treated Advanced Non-Small-Cell Lung Cancer in China (2022 · Frontiers in Pharmacology · 被引 23)
• Targeting of non-apoptotic cancer cell death mechanisms by quercetin: Implications in cancer therapy (2022 · Frontiers in Pharmacology · 被引 22)
• Cost-Effectiveness Analysis of Anlotinib as Third- or Further-Line Treatment for Relapsed Small Cell Lung Cancer (SCLC) in China (2021 · Advances in Therapy · 被引 21)